ICCC ImmuCell Corporation
$10.25▲ +0.38%
Healthcare
Other
Volume 2.5K
Avg Volume (10D) 11.0K
Key Metrics & Fundamentals
Market Cap
$93.09M
P/E Ratio
146.4
Div Yield
0.00%
52W Range
4.52 - 12.10
% vs 50 MA
2.37%
% vs 200 MA
16.54%
RSI-14
51.1
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.42
Free Cash Flow
$2.29M
Gross Rev
$7.19M
Gross Profit
$2.44M
EBITDA
$2.44M
COGS
$4.75M
Operating Exp
$502,288
Operating Income
$1.93M
EBIT
$1.93M
Pretax Income
$1.88M
Net Income
$1.83M
EPS (Diluted)
0.20
Price & Volume History
Loading chart…
Recent News

ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?
Zacks · Oct 21, 2026 10:31 AM ET
ImmuCell Q3 Preliminary Sales Rise
MT Newswires · Oct 12, 2026 4:47 PM ET

ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
GlobeNewswire · Oct 12, 2026 4:05 PM ET

The Zacks Analyst Blog Highlights Alphabet, Mastercard, AbbVie, Perma-Pipe and ImmuCell
Zacks · Sep 29, 2026 2:23 AM ET
Top Research Reports for Alphabet, Mastercard & AbbVie
Zacks · Sep 28, 2026 3:49 PM ET

ImmuCell Stock Falls 8.8% Despite Y/Y Earnings & Sales Growth in Q2
Zacks · Aug 27, 2026 10:10 AM ET

ImmuCell (ICCC) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 6:45 PM ET
ImmuCell Corp (ICCC) (Q2 2026) Earnings Call Highlights: Record Net Income and Market Share ...
GuruFocus.com · Aug 14, 2026 7:01 PM ET

ImmuCell Q2 Earnings Call Highlights
MarketBeat · Aug 14, 2026 10:04 AM ET

ImmuCell Corporation Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ICCC's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.